Tenon Medical (TNON) Cash from Financing Activities (2021 - 2026)

Tenon Medical's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $3.9 million for Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 38.22% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was $6.6 million, a 58.8% decrease from a year earlier, with the FY2025 full-year figure at $9.0 million, down 36.36% from the prior year.
• Cash from Financing Activities improved to $3.9 million in Q1 2026 per TNON's latest filing, from $2.7 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $14.2 million in Q2 2022 and bottomed at -$59000.0 in Q2 2025.
• The 5-year median for Cash from Financing Activities is $1.4 million (2023), against an average of $3.2 million.
• Across the five-year window, Cash from Financing Activities soared 10507.14% in 2024 and slumped 99.39% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at -$25000.0 in 2022, then jumped by 5584.0% to $1.4 million in 2023, then slumped by 91.76% to $113000.0 in 2024, then soared by 2315.93% to $2.7 million in 2025, then jumped by 41.65% to $3.9 million in 2026.
• Per Business Quant, the three latest TNON Cash from Financing Activities figures stand at $3.9 million (Q1 2026), $2.7 million (Q4 2025), and $59000.0 (Q3 2025).